Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer

ClinicalTrials.gov ID: NCT00570713

Public ClinicalTrials.gov record NCT00570713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Placebo-controlled, Double-blind Study of the Efficacy of MORAb-009 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer.

Study identification

NCT ID
NCT00570713
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Morphotek
Industry
Enrollment
155 participants

Conditions and interventions

Interventions

  • MORAb-009 Drug
  • Placebo Drug
  • Gemcitabine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Nov 30, 2009
Completion
Nov 30, 2009
Last update posted
Sep 8, 2015

2007 – 2009

United States locations

U.S. sites
26
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Moores UCSD Cancer Center La Jolla California 92037-0845
Southern California Permanente Medical Group San Diego California 92108
Sharp Memorial Hospital San Diego California 92123
Kaiser Permanente Vallejo California 94589
Cancer Center of Central Connecticut Southington Connecticut 06489
Connecticut Oncology & Hematology Torrington Connecticut 06790
Palm Beach Institute of Hematology and Oncology Boynton Beach Florida 33435
Baptist Cancer Institute - Jacksonville Jacksonville Florida 32207
Hematology Oncology Associates of the Palm Beaches Lake Worth Florida 33461
Hematology-Oncology Associates of Illinois, LLC Skokie Illinois 60076
Carle Clinic Assoc. Urbana Illinois 61801
University of Kansas Medical Center Westwood Kansas 66205
Jayne Gurtler, MD, Laura Brinz, MD, & Angelo Russo, MD Metairie Louisiana 70006
Providence Cancer Center, Oncology, Clinical Trials Southfield Michigan 48075
The Center for Cancer and Hematologic Disease Cherry Hill New Jersey 08003
Arena Oncology Associates, P.C. Lake Success New York 11042
Hanover Medical Specialists, MD Wilmington North Carolina 28401
Gabrail Cancer Center Canton Ohio 44718
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232
South Carolina Oncology Associates, PA Columbia South Carolina 10595
Arlington Cancer Center Arlington Texas 76012
Baylor College of Medicine Houston Texas 77030
South Texas Onocology Hemotology, PA San Antonio Texas 78229
Providence Western Washington Oncology Lacey Washington 98503
Medical College of Wisconsin Clinical Cancer Center Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00570713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00570713 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →